PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study.
Amina BandaBastiaan M PrivéYoussra AllachMaike J M UijenSteffie M B PetersCato C LoeffMartin GotthardtConstantijn H J MuselaersJ Alfred WitjesInge M van OortJ P Michiel SedelaarHarm WestdorpNiven MehraFadi KhreishSamer EzziddinAmir SabetMichael Christoph KreisslThomas WinkensPhilipp SeifertMarcel J R JanssenWillemijn A M van GemertJames NagarajahPublished in: Cancers (2022)
In this small cohort study, PSMA-RLT appeared safe and showed encouraging efficacy for (metastasized) early-stage and hormone-sensitive prostate cancer patients. Prospective studies are awaited and should include long-term follow-up.